Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

25

Number of overlapping holdings

21.2%

% of XBI's 119 holdings also in CANC

51.0%

% of CANC's 49 holdings also in XBI

Overlap by Weight
Sector Drift (XBI minus CANC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XBI
Weight
in CANC
Overlap
BLUEPRINT MEDICINES CORP. 2.5% 2.8% 2.5%
AMGEN INC 2.3% 2.7% 2.3%
EXELIXIS INC 2.1% 3.9% 2.1%
ABBVIE INC 2.4% 2.0% 2.0%
BRIDGEBIO PHARMA, INC. 1.8% 4.3% 1.8%

Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to CANC
EXACT SCIENCES CORP 3.1%
NEUROCRINE BIOSCIENCES INC 2.9%
NATERA INC 2.9%
ALNYLAM PHARMACEUTICALS INC 2.8%
UNITED THERAPEUTICS CORP 2.7%
INSMED INC 2.4%
VERTEX PHARMACEUTICALS INC 2.4%
BIOGEN IDEC INC 2.3%
MADRIGAL PHARMACEUTICALS, INC. 2.2%
BIOMARIN PHARMACEUTICAL INC 2.0%
XBI Underweight Relative to CANC
ROCHE HOLDINGS LTD-SPONS ADR -5.1%
ELI LILLY & CO -4.8%
REVOLUTION MEDICINES, INC. -4.6%
NOVARTIS AG -4.3%
ASTRAZENECA PLC -4.3%
BRISTOL-MYERS SQUIBB CO -3.8%
GENMAB A/S SPONSORED ADR -3.5%
ZAI LAB LTD. UNSPONSORED ADR -3.1%
MERUS N.V. -3.1%
NUVALENT, INC. CLASS A -3.0%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY